|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2010-11-30
|
|
pubmed:abstractText |
Few studies evaluated the efficacy of HCV re-treatment and the predictors of response in HIV/HCV co-infected patients. The role of insulin resistance as a predictor of response in this population is unknown. The aim of this study is to evaluate the safety and efficacy of pegylated interferon-?-2a and ribavirin in re-treatment of HIV/HCV co-infected patients, predictors of sustained virological response, including insulin resistance, and the relationship between insulin resistance and liver histology.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0168-8278
|
|
pubmed:author |
pubmed-author:BräuNorbertN,
pubmed-author:BranchAndrea DAD,
pubmed-author:DieterichDouglas TDT,
pubmed-author:FactorStephanie HSH,
pubmed-author:FielMaria-IsabelMI,
pubmed-author:Rodriguez-TorresMaribelM,
pubmed-author:SlimJihadJ,
pubmed-author:SterlingRichard KRK,
pubmed-author:SulkowskiMark SMS,
pubmed-author:TalalAndrew HAH,
pubmed-author:VachonMarie-Louise CML
|
|
pubmed:copyrightInfo |
Copyright © 2010 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
54
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
41-7
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:20974502-Adult,
pubmed-meshheading:20974502-Antiviral Agents,
pubmed-meshheading:20974502-Case-Control Studies,
pubmed-meshheading:20974502-Female,
pubmed-meshheading:20974502-HIV Infections,
pubmed-meshheading:20974502-Hepatitis C, Chronic,
pubmed-meshheading:20974502-Humans,
pubmed-meshheading:20974502-Insulin Resistance,
pubmed-meshheading:20974502-Interferon-alpha,
pubmed-meshheading:20974502-Liver,
pubmed-meshheading:20974502-Male,
pubmed-meshheading:20974502-Middle Aged,
pubmed-meshheading:20974502-Polyethylene Glycols,
pubmed-meshheading:20974502-Prospective Studies,
pubmed-meshheading:20974502-RNA, Viral,
pubmed-meshheading:20974502-Recombinant Proteins,
pubmed-meshheading:20974502-Ribavirin,
pubmed-meshheading:20974502-Treatment Failure
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Insulin resistance predicts re-treatment failure in an efficacy study of peginterferon-?-2a and ribavirin in HIV/HCV co-infected patients.
|
|
pubmed:affiliation |
Division of Liver Diseases, Mount Sinai School of Medicine, NY, USA. marie-louise.vachon@mountsinai.org
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase III,
Research Support, N.I.H., Extramural
|
